The IL13α 2R paves the way for anti-glioma nanotherapy
Glioblastoma (GBM) is one of the most aggressive (grade IV) gliomas characterized by a high rate of recurrence, resistance to therapy and a grim survival prognosis. The long-awaited improvement in GBM patients’ survival rates essentially depends on advances in the development of new therapeutic appr...
Main Authors: | Ilya V. Ulasov, Anton Borovjagin, Anastasia Laevskaya, Margarita Kamynina, Peter Timashev, Laura Cerchia, Elena A. Rozhkova |
---|---|
Format: | Article |
Language: | English |
Published: |
KeAi Communications Co., Ltd.
2023-01-01
|
Series: | Genes and Diseases |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352304221001033 |
Similar Items
-
Clinical Significance and Systematic Expression Analysis of the Thyroid Receptor Interacting Protein 13 (TRIP13) as Human Gliomas Biomarker
by: Ssu-Han Chen, et al.
Published: (2021-05-01) -
Metabolome-Driven Regulation of Adenovirus-Induced Cell Death
by: Anastasia Laevskaya, et al.
Published: (2021-01-01) -
Oncolytic Virus-Induced Autophagy in Glioblastoma
by: Margarita Kamynina, et al.
Published: (2021-07-01) -
Multi-parametric hyperpolarized 13C/1H imaging reveals Warburg-related metabolic dysfunction and associated regional heterogeneity in high-grade human gliomas
by: Adam W. Autry, et al.
Published: (2023-01-01) -
IL-13Rα2 Status Predicts GB-13 (IL13.E13K-PE4E) Efficacy in High-Grade Glioma
by: Julian S. Rechberger, et al.
Published: (2022-04-01)